https://prabadinews.com/
Oveporexton Demonstrates Statistically Significant, Clinically Meaningful Improvements in Patients With NT1

In 2 clinical trials, oveporexton shows promise in treating narcolepsy type 1 (NT1), paving the way for potential FDA approval.

administrator

Related Articles